HealthStream Inc. Reports Q2 2025 Revenues of $674.4M, Adjusted EBITDA of $517.6M, Surpassing FY 2024 Revenues of $6,291.6M

Reuters
08/12
HealthStream Inc. Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenues of $674.4M, Adjusted EBITDA of $517.6M, Surpassing FY 2024 Revenues of $6,291.6M

HealthStream Inc. has reported its financial results for the second quarter of 2025, revealing revenues of $674.4 million. This represents an increase from the fiscal year 2024 revenues, which stood at $6291.6 million. Additionally, the company's quarterly adjusted EBITDA reached $517.6 million, compared to the fiscal year 2024 adjusted EBITDA of $566.8 million. HealthStream boasts a strong balance sheet with $690.6 million in cash as of the second quarter of 2025 and no debt. The company continues to serve the U.S. healthcare industry with enterprise-level, subscription-based products, generating recurring revenues. HealthStream remains a market leader in workforce solutions for learning, credentialing, and scheduling within healthcare organizations. The company is focused on addressing the industry's challenges in improving patient safety and workforce retention.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthStream Inc. published the original content used to generate this news brief on August 11, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10